NCT05779943View on ClinicalTrials.gov

Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 27, 2023

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2028

Conditions
Prostate AdenocarcinomaRecurrent Prostate Carcinoma
Interventions
DRUG

Furosemide

Given IV

OTHER

F18-rhPSMA-7.3

Given IV

PROCEDURE

Positron Emission Tomography

Undergo PET/CT scan

PROCEDURE

Computed Tomography

Undergo PET/CT scan

Trial Locations (4)

30097

Emory Johns Creek Hospital, Johns Creek

30308

Emory University Hospital Midtown, Atlanta

30322

Emory University Hospital/Winship Cancer Institute, Atlanta

30342

Emory Saint Joseph's Hospital, Atlanta

Sponsors

Collaborators (1)

Blue Earth Diagnostics
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Blue Earth Diagnostics

INDUSTRY

lead

Emory University

OTHER